Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hillary Mulder

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Vascular Medicine (London, England)|September 13, 2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trialLars Norgren, Rebecca North, Iris Baumgartner, et al.
Journal of Cardiac Failure|July 3, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes ModelRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.
Circulation. Cardiovascular Interventions|October 12, 2020
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialJennifer A Rymer, Hillary Mulder, Dennis I Narcisse, et al.
American Heart Journal|December 24, 2018
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trialKaren P Alexander, Marc A Brouwer, Hillary Mulder, et al.
JAMA Cardiology|December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialChristoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Journal of the American Heart Association|September 14, 2020
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) TrialJennifer A Rymer, Hillary Mulder, Kim G Smolderen, et al.
Pediatric Cardiology|June 8, 2023
Impact of Prenatal Diagnosis of Critical Congenital Heart Disease on Preoperative and Postoperative OutcomesAshley N Dischinger, Jennifer S Li, Hillary Mulder, et al.
Journal of the American Heart Association|November 4, 2024
Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health SystemsNishant P Shah, Hillary Mulder, Elizabeth Lydon, et al.
Journal of Cardiac Failure|January 31, 2025
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID TrialJustin A Ezekowitz, Hillary Mulder, Robert J Mentz, et al.
Lung|January 23, 2022
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry CohortJamie L Todd, Megan L Neely, Robert Overton, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Vascular Medicine (London, England)|September 13, 2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trialLars Norgren, Rebecca North, Iris Baumgartner, et al.
Journal of Cardiac Failure|July 3, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes ModelRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.
Circulation. Cardiovascular Interventions|October 12, 2020
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialJennifer A Rymer, Hillary Mulder, Dennis I Narcisse, et al.
American Heart Journal|December 24, 2018
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trialKaren P Alexander, Marc A Brouwer, Hillary Mulder, et al.
JAMA Cardiology|December 13, 2018
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID TrialChristoph B Olivier, Hillary Mulder, William R Hiatt, et al.
Journal of the American Heart Association|September 14, 2020
Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) TrialJennifer A Rymer, Hillary Mulder, Kim G Smolderen, et al.
Pediatric Cardiology|June 8, 2023
Impact of Prenatal Diagnosis of Critical Congenital Heart Disease on Preoperative and Postoperative OutcomesAshley N Dischinger, Jennifer S Li, Hillary Mulder, et al.
Journal of the American Heart Association|November 4, 2024
Lipoprotein (a) Testing in Patients With Atherosclerotic Cardiovascular Disease in 5 Large US Health SystemsNishant P Shah, Hillary Mulder, Elizabeth Lydon, et al.
Journal of Cardiac Failure|January 31, 2025
Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID TrialJustin A Ezekowitz, Hillary Mulder, Robert J Mentz, et al.
Lung|January 23, 2022
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry CohortJamie L Todd, Megan L Neely, Robert Overton, et al.
Pageof 8